North American Morning Briefing: Investor Mood -3-
Goeasy: Well-Placed to Adapt to Potential Rate Change by Accelerating Strategy of Continously Reducing Weighted Average Interest Rate Charged to Borrowers; To Keep Expanding Products, Distribution Channels, Leveraging Risk-Based Pricing to Cut Borrowing Costs for Consumers;
Has Also Raised Senior Secured Revolving Credit Facility by C$100M to C$370M; Has Received Approval From Canadian Insurer for C$150M of Additional Financing;
Enhancements Complement Existing C$1.6B Revolving Securitization Warehouse Facilities, Will Be Used for General Purposes; Confident That Existing Funding Facilities, Ability to Raise Additional Debt Financing, Will Fund Organic Growth Targets
---
Sierra Metals 4Q Revenue From Metals Payable $46.2 M; 4Q Loss/Shr 16c; Special Committee Continues to Evaluate Certain Strategic Alternatives
Expected Major Events for Wednesday
06:00/GER: Apr GfK consumer climate survey
06:45/FRA: Feb Housing starts
06:45/FRA: Mar Consumer confidence survey
08:00/ITA: Feb Foreign Trade non-EU
08:30/UK: Feb Monetary & Financial Statistics
08:30/UK: Feb Bank of England effective interest rates
08:30/UK: Feb Money and Credit - Lending to Individuals, Lending to Businesses, Broad Money and Credit
11:00/US: 03/24 MBA Weekly Mortgage Applications Survey
12:30/US: 4Q U.S. International Investment Position
14:00/US: Feb Pending Home Sales Index
14:30/US: 03/24 EIA Weekly Petroleum Status Report
23:01/UK: Feb UK monthly automotive manufacturing figures
23:01/UK: Mar CBI Growth Indicator and Service Sector Survey
23:50/JPN: Mar Provisional Trade Statistics for 1st 10 days of Month
All times in GMT. Powered by Onclusive and Dow Jones.
Expected Earnings for Wednesday
Abraxas Petroleum (AXAS) is expected to report for 4Q.
Accelerate Diagnostics Inc (AXDX) is expected to report $-0.13 for 4Q.
Aerovate Therapeutics Inc (AVTE) is expected to report for 4Q.
Arlington Asset Investment Corp (AAIC) is expected to report $0.04 for 4Q.
Atreca Inc (BCEL) is expected to report for 4Q.
Avalo Therapeutics Inc (AVTX) is expected to report for 4Q.
Axcella Health Inc (AXLA) is expected to report for 4Q.
Cathedral Energy Services (CET.T) is expected to report for 4Q.
Cintas Corp (CTAS) is expected to report $2.99 for 3Q.
Clovis Oncology Inc (CLVSQ) is expected to report $-1.72 for 4Q.
Codiak BioSciences Inc (CDAK) is expected to report for 4Q.
Conn's (CONN) is expected to report $-0.88 for 4Q.
Constellation Software (CSU.T) is expected to report $6.25 for 4Q.
Dollarama (DLMAF,DOL.T) is expected to report $0.88 for 4Q.
Excellon Resources (EXN.T) is expected to report for 4Q.
GlycoMimetics Inc (GLYC) is expected to report $-0.17 for 4Q.
Lightbridge Corp (LTBR) is expected to report for 4Q.
Local Bounti Corp (LOCL) is expected to report for 4Q.
Lyra Therapeutics Inc (LYRA) is expected to report for 4Q.
Microbot Medical Inc (MBOT) is expected to report for 4Q.
Neptune Wellness Solutions Inc (NEPT,NEPT-T) is expected to report for 3Q.
NexImmune Inc (NEXI) is expected to report for 4Q.
Odyssey Marine Exploration Inc (OMEX) is expected to report for 4Q.
Oncocyte Corp (OCX) is expected to report $-0.09 for 4Q.
Paychex Inc (PAYX) is expected to report $1.24 for 3Q.
Pieris Pharmaceuticals Inc (PIRS) is expected to report $-0.21 for 4Q.
Professional Diversity Network Inc (IPDN) is expected to report for 4Q.
ReShape Lifesciences Inc (RSLS) is expected to report for 4Q.
Reading International Inc (RDI) is expected to report $0.10 for 4Q.
Security National Financial Corp (SNFCA) is expected to report for 4Q.
Semtech (SMTC) is expected to report $0.27 for 4Q.
Sharecare Inc (SHCR) is expected to report for 4Q.
Tattooed Chef Inc (TTCF) is expected to report for 4Q.
Telesat Corp (TSAT) is expected to report for 4Q.
TuSimple Holdings Inc (TSP) is expected to report for 4Q.
US Global Investors (GROW) is expected to report for 2Q.
UniFirst Corp (UNF) is expected to report $1.02 for 2Q.
Vyant Bio Inc (VYNT) is expected to report for 4Q.
bluebird bio Inc (BLUE) is expected to report $-0.38 for 4Q.
iSign Solutions Inc (ISGN) is expected to report for 4Q.
Powered by Onclusive and Dow Jones.
ANALYST RATINGS ACTIONS
Adobe Raised to Buy From Hold by Erste Group
Applied Molecular Trnsprt Cut to Neutral From Buy by Chardan Capital
Array Technologies Raised to Buy From Hold by Truist Securities
Carnival Raised to Equal-Weight From Underweight by Wells Fargo
Ciena Raised to Strong Buy From Outperform by Raymond James
Coherus BioSciences Raised to Buy From Neutral by UBS
Easterly Govt Properties Raised to Buy From Neutral by Compass Point
Elevance Health Raised to Outperform From Sector Perform by RBC Capital
Encore Capital Group Raised to Buy From Neutral by Janney Montgomery Scott
FactSet Research Raised to Neutral From Sell by Redburn Partners
Fox Corp. Cut to Neutral From Buy by B of A Securities
Genesco Raised to Buy From Neutral by Seaport Global
iHeartMedia Cut to Underperform From Neutral by B of A Securities
Marathon Petroleum Cut to Neutral From Overweight by JP Morgan
NextEra Energy Raised to Buy From Hold by Erste Group
Occidental Petroleum Raised to Outperform From Market Perform by TD Cowen
Paramount Global Raised to Buy From Neutral by B of A Securities
Parsons Raised to Outperform From Market Perform by William Blair
TD SYNNEX Cut to Hold From Buy by CFRA
Venus Concept Cut to Hold From Buy by Maxim Group
Walmart Cut to Hold From Buy by Erste Group
This article is a text version of a Wall Street Journal newsletter published earlier today.
(END) Dow Jones Newswires
March 29, 2023 06:13 ET (10:13 GMT)
Copyright (c) 2023 Dow Jones & Company, Inc.